Yuanxiang Wang

15PUBLICATIONS
15CO-AUTHORS
Vision scienceMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 09, 2025
Sorting nexin 3 promotes ischemic retinopathy through RIP1- and RIP3-mediated myeloid cell necroptosis and mitochondrial fission.

Jiaojiao Wang, Chunhong Zhou, Kai Zhuang

|Aug 22, 2025
PRMT5: A Promising Synthetical Lethal Target for MTAP-Deleted Cancers.

Bang Li, Jin-Qi Yu, Zhenjiao Yang

|May 20, 2025
Phase separation of RXRγ drives tumor chemoresistance and represents a therapeutic target for small-cell lung cancer.

Hong Wang, Jie Huang, Zhenhua Zhang

|May 09, 2025
Discovery of Highly Potent and Selective EZH2 Covalent Inhibitors via Incorporating Basic Amines.

Yi Zhang, Qiongyu Shi, Wei Fang

|Oct 15, 2024
Correction to "Discovery of a Highly Potent Lysine Methyltransferases G9a/NSD2 Dual Inhibitor to Treat Solid Tumors".

Chunju Yang, Bang Li, Zongbo Feng

|Sep 04, 2024
Discovery of a Highly Potent and Selective Inhibitor Targeting Protein Lysine Methyltransferase NSD2.

Jianwei Wei, Qiongyu Shi, Bang Li

Pageof 3

Frequent Collaborators

2 joint publications

Xiao-Feng Xiong

2 joint publications

Zhong-Zhu Chen

1 joint publications

Wenhao Hu

1 joint publications

Chang-Yun Wang